Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q1 2026

Amesite Q1 2026 Results: Net Loss of $774K, Loss Widens

Amesite Inc. reported a net loss of $774,395 for the quarter ended September 30, 2026, compared to a loss of $642,266 in the prior year period, driven by increased technology and content development costs. The company's management expressed substantial doubt about its ability to continue as a going concern, noting that current cash reserves may not sustain operations for the next twelve months.

Q1 2026 at a glance · $ million
MetricQ1 2026Q1 2025
Revenue0.10.1
Net income-0.8-0.6
EPS (diluted, $ a share)$-0.12$-0.14

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-25.5%
Source

10-Q filed with the SEC, NASDAQ: AMST. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Amesite Inc.: key numbers

Share price
$0.5468Close, Nov 16
Market cap
$3.58M
Shares outstanding
6.55MLatest SEC cover page
Sector
Technology
Industry
Services-Prepackaged SoftwareSIC 7372

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Amesite Inc.

All →
6:16 AM ET 8-K
Contract Win

Amesite Announces Contract Win

Amesite Inc. entered into a new NurseMagic enterprise agreement with a healthcare organization serving approximately 2,000 patients. The contract involves deploying Amesite's AI-native documentation platform to automate EMR assessments and care plans. While the specific counterparty name and deal value were not disclosed, the company framed the win as a material expansion of its recurring revenue and enterprise user base.

4:01 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Amesite Nasdaq/NYSE Compliance Notice

Amesite Inc. received a deficiency notice from Nasdaq on November 11, 2026, for failing to maintain the minimum $1.00 bid price requirement for 30 consecutive business days. The company has 180 calendar days, until May 10, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Management is monitoring the situation and may consider a reverse stock split if necessary to maintain its listing on The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
4:26 PM ET 8-K
Shareholder Meeting

Amesite Shareholder Meeting

Amesite Inc. has scheduled its next Annual Meeting of Stockholders for December 10, 2026. The company established September 27, 2026, as the deadline for stockholders to submit proposals or director nominations for inclusion in the proxy materials.

9:09 AM ET 8-K
Investor Presentation

Amesite Investor Presentation

Amesite Inc. has prepared presentation materials for use at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026. The presentation highlights the company's AI-powered enterprise solutions for the $1.5 trillion post-acute care market, including its NurseMagic B2B platform and EMR functionality. The company reported international reach across 21 countries and high user ratings for its clinical documentation applications.

Counterparty
H.C. Wainwright 28th Annual Global Investment Conference

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.